Patients were found to have similar completion and yield rates for the fecal immunochemical test (FIT) at both 45 years and ...

By 2021, neoadjuvant chemotherapy followed by interval cytoreductive surgery became the most common initial treatment for ...

The AMCP Nexus 2024 annual meeting covered a variety of hot health care topics impacting managed care pharmacy in the present ...

Investigators said the unique features of chimeric antigen receptor (CAR) T-cell therapy may warrant novel approaches to cost ...

Examining care transitions in hospitalized patients revealed lower diagnostic error rates compared with traditional methods, ...

Delayed diagnosis of fibrotic ILD leads to higher mortality rates and shorter overall survival, emphasizing the need for ...

Mabel Mardones, MD, board certified medical oncologist and hematologist who specializes in breast cancer at Rocky Mountain Cancer Centers, emphasizes the importance in identifying patients with ...

In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the ...

Many women remain unaware that the Affordable Care Act (ACA) mandates cost-free preventive services; however, ongoing legal ...

Study explores the clinical manifestations, risk factors, and 90-day mortality outcomes in adults hospitalized with RSV or ...

Panelists discuss how payer perspectives and access challenges impact the utilization of HER2-directed therapies in NSCLC, ...

Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses advancements in breast cancer treatment, highlighting CDK4/6 inhibitors and ...